# A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

> **NCT06501911** · PHASE1 · WITHDRAWN · sponsor: **University of Nebraska**

## Conditions studied

- Recurrent Glioblastoma
- Recurrent High-grade Glioma

## Interventions

- **DRUG:** Bicalutamide
- **RADIATION:** Intensity-modulated radiation therapy (IMRT)

## Key facts

- **NCT ID:** NCT06501911
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04-08
- **Primary completion:** 2025-07-17
- **Final completion:** 2025-07-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI leaving institution.
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501911, "A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06501911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*